Neurodevelopmental Assessment of Infants With Cystic Fibrosis

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

June 11, 2018

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2021

Conditions
Neurodevelopmental DisordersCystic Fibrosis
Interventions
OTHER

Neurodevelopmental assessments

Infants' neurodevelopmental assessments will be done by the Bayley-III Baby and Child Development Assessment Scale (Bayley III) and the Gross Motor Function Measure. Bayley-III assess the development of five distinct scales to be consistent with areas of appropriate developmental assessment for children from birth to age 3. The Bayley-III revision includes Cognitive, Language, Motor, Social-Emotional, and Adaptive Behavior scales.The Gross Motor Function Measure (GMFM) has 5 dimensions: A-lying and roll- ing; B-sitting; C- kneeling and crawl- ing; D-standing; and E-walking, run- ning, and jumping. The items are scored from 0 to 3. All items are summarized and expressed as a value of total points for each dimension of the GMFM.

Trial Locations (1)

06100

Hacettepe University, Ankara

All Listed Sponsors
lead

Hacettepe University

OTHER

NCT03577756 - Neurodevelopmental Assessment of Infants With Cystic Fibrosis | Biotech Hunter | Biotech Hunter